Department of Biological Sciences, Dental Faculty, Toulouse University Hospital, University of Toulouse, Toulouse, France.
CNRS ERL 5311, EFS, INPENVT, INSERM U1031, UPS, STROMALab, University of Toulouse, Toulouse, France.
Stem Cells Transl Med. 2017 Feb;6(2):656-665. doi: 10.5966/sctm.2016-0028. Epub 2016 Sep 16.
Current treatment of periodontitis is still associated with a high degree of variability in clinical outcomes. Recent advances in regenerative medicine by mesenchymal cells, including adipose stromal cells (ASC) have paved the way to improved periodontal regeneration (PD) but little is known about the biological processes involved. Here, we aimed to use syngeneic ASCs for periodontal regeneration in a new, relevant, bacteria-induced periodontitis model in mice. Periodontal defects were induced in female C57BL6/J mice by oral gavage with periodontal pathogens. We grafted 2 × 10 syngeneic mouse ASCs expressing green fluorescent protein (GFP) (GFP+/ASC) within a collagen vehicle in the lingual part of the first lower molar periodontium (experimental) while carrier alone was implanted in the contralateral side (control). Animals were sacrificed 0, 1, 6, and 12 weeks after treatment by GFP+/ASC or vehicle graft, and microscopic examination, immunofluorescence, and innovative bio-informatics histomorphometry methods were used to reveal deep periodontium changes. From 1 to 6 weeks after surgery, GFP+ cells were identified in the periodontal ligament (PDL), in experimental sites only. After 12 weeks, cementum regeneration, the organization of PDL fibers, the number of PD vessels, and bone morphogenetic protein-2 and osteopontin expression were greater in experimental sites than in controls. Specific stromal cell subsets were recruited in the newly formed tissue in ASC-implanted periodontium only. These data suggest that ASC grafting in diseased deep periodontium, relevant to human pathology, induces a significant improvement of the PDL microenvironment, leading to a recovery of tooth-supporting tissue homeostasis. Stem Cells Translational Medicine 2017;6:656-665.
目前,牙周炎的治疗仍然与临床疗效的高度变异性相关。间充质细胞(包括脂肪基质细胞 [ASC])的再生医学的最新进展为改善牙周再生(PD)铺平了道路,但对涉及的生物学过程知之甚少。在这里,我们旨在使用同源 ASC 来治疗小鼠新的、相关的、细菌诱导的牙周炎模型中的牙周炎。通过口腔灌胃牙周病原体,在雌性 C57BL6/J 小鼠的第一下磨牙牙周组织的舌侧部分诱导牙周缺损。我们将表达绿色荧光蛋白(GFP)的 2×10 个同源鼠 ASC(GFP+/ASC)植入胶原载体中(实验组),而在对侧植入载体(对照组)。在 GFP+/ASC 或载体移植物治疗后 0、1、6 和 12 周时,通过 GFP+/ASC 或载体移植物处死动物,并进行显微镜检查、免疫荧光和创新的生物信息学组织形态计量学方法,以揭示深层牙周组织的变化。手术后 1 至 6 周,仅在实验组的牙周韧带(PDL)中鉴定出 GFP+细胞。12 周后,实验组的牙骨质再生、PDL 纤维组织、PD 血管数量以及骨形态发生蛋白-2 和骨桥蛋白的表达均大于对照组。仅在 ASC 植入的牙周组织中募集了特定的基质细胞亚群。这些数据表明,在与人类病理学相关的患病深层牙周组织中植入 ASC 可显著改善 PDL 微环境,从而恢复牙齿支持组织的稳态。Stem Cells Translational Medicine 2017;6:656-665.